Olaparib Monotherapy Yields Good PSA Response Rates in Prostate Cancer
Response rates seen in patients with high-risk biochemically recurrent prostate cancer after radical prostatectomy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.